OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Radioiodine therapy in advanced differentiated thyroid cancer: Resistance and overcoming strategy
Yujia Liu, Jiafeng Wang, Xiao Hu, et al.
Drug Resistance Updates (2023) Vol. 68, pp. 100939-100939
Open Access | Times Cited: 25

Showing 25 citing articles:

Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Bilan Wang, Shiqi Hu, Yan Teng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 56

Developing a named entity framework for thyroid cancer staging and risk level classification using large language models
Matrix Man Him Fung, Eric Ho Man Tang, Tingting Wu, et al.
npj Digital Medicine (2025) Vol. 8, Iss. 1
Open Access

GGCT Inhibits Ferroptosis in PTC Cells by Upregulating p53 Through RPS15A
Hui‐min Zhang, Hanning Li, Enbo Qi, et al.
Cancer Science (2025)
Open Access

Global research landscape and trends of papillary thyroid cancer therapy: a bibliometric analysis
Bo Song, Zheyu Lin, Chuyao Feng, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 12

Icariin as a potential anticancer agent: a review of its biological effects on various cancers
Fang-Yuan Liu, Dan‐Ni Ding, Yun-Rui Wang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 11

Thyroid cancer and cardiovascular diseases: a Mendelian randomization study
Yamei Gao, Zhijia Wang, Jinsheng Yu, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 3

LINC01089 in cancer: multifunctional roles and therapeutic implications
Qiang Yi, Gangfeng Zhu, Xinting Ouyang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3

Radioiodine-refractory differentiated thyroid cancer: Molecular mechanisms and therapeutic strategies for radioiodine resistance
Huize Shen, Rui Zhu, Yanyang Liu, et al.
Drug Resistance Updates (2023) Vol. 72, pp. 101013-101013
Open Access | Times Cited: 9

Choice of management strategy for papillary thyroid microcarcinoma: active surveillance or immediate surgery?
Qi Liu, Mingyuan Song, Hao Zhang
Journal of Cancer (2024) Vol. 15, Iss. 4, pp. 1009-1020
Open Access | Times Cited: 2

How to Manage Advanced Differentiated Thyroid Cancer: Step-by-Step Analysis from Two Italian Tertiary Referral Centers
Paola Sartori, Sara Andreani, Loredana De Pasquale, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 3, pp. 708-708
Open Access | Times Cited: 2

The evolving process of ferroptosis in thyroid cancer: Novel mechanisms and opportunities
Lin Yin, Xiaodan Luo, Xian Zhang, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 16
Open Access | Times Cited: 2

Novel Platinum(IV) complexes intervene oxaliplatin resistance in colon cancer via inducing ferroptosis and apoptosis
Zhikun Liu, Jinyuan Cai, Guiyang Jiang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 263, pp. 115968-115968
Closed Access | Times Cited: 7

In silicoscreening combined with bioactivity evaluation to identify AMI-1 as a novel anticancer compound by targeting AXL
Linxiao Wang, Yufeng An, Xiongpiao Wei, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 15, pp. 7686-7698
Closed Access | Times Cited: 6

Research progress of plant-derived natural products in thyroid carcinoma
Qiujing Du, Wei-Dong Shen
Frontiers in Chemistry (2024) Vol. 11
Open Access | Times Cited: 1

TIPARP as a prognostic biomarker and potential immunotherapeutic target in male papillary thyroid carcinoma
Jianlin Zhang, Xumin Zhou, Fan Yao, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1

Systemic Immune-Inflammation Index and Systemic Inflammation Response Index Predict the Response to Radioiodine Therapy for Differentiated Thyroid Cancer
Yan Wang, Junshun Chang, Ben Hu, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 8531-8541
Open Access | Times Cited: 1

tRF-1:30-Gly-CCC-3 inhibits thyroid cancer via binding to PC and modulating metabolic reprogramming
Bifei Fu, YuMing Lou, Xiaofeng Lu, et al.
Life Science Alliance (2023) Vol. 7, Iss. 3, pp. e202302285-e202302285
Open Access | Times Cited: 2

Dual agonism of sodium iodide symporter functionin vivo
Katie Brookes, Caitlin E.M. Thornton, Ling Zha, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Ophiopogonin D′ inhibited tumour growth and metastasis of anaplastic thyroid cancer by modulating JUN/RGS4 signalling
Tong Xu, Wanli Zhang, Yiwen Zhang, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 16
Open Access

[68Ga]Ga-LNC1007 versus 2-[18F]FDG in the evaluation of patients with metastatic differentiated thyroid cancer: a head-to-head comparative study
Yun Chen, Shan Zheng, Jie Zang, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024)
Closed Access

Clinical Implications of Dually Targeting the Sodium Iodide Symporter in Canonical and Non-Canonical Settings
Katie Brookes, Caitlin E.M. Thornton, Ling Zha, et al.
(2024)
Closed Access

Case report: A rare case of breast and multiorgan metastases secondary to papillary thyroid carcinoma
Huang Wen-qin, Yalong Yang, Peng Zhan, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access

Page 1

Scroll to top